|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
US9950282B2
(en)
|
2012-03-15 |
2018-04-24 |
Flodesign Sonics, Inc. |
Electronic configuration and control for acoustic standing wave generation
|
|
US10967298B2
(en)
|
2012-03-15 |
2021-04-06 |
Flodesign Sonics, Inc. |
Driver and control for variable impedence load
|
|
US9458450B2
(en)
|
2012-03-15 |
2016-10-04 |
Flodesign Sonics, Inc. |
Acoustophoretic separation technology using multi-dimensional standing waves
|
|
WO2015105955A1
(en)
|
2014-01-08 |
2015-07-16 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
AU2015330699B2
(en)
|
2014-10-10 |
2021-12-02 |
Editas Medicine, Inc. |
Compositions and methods for promoting homology directed repair
|
|
EP4464338A3
(en)
|
2014-11-07 |
2025-02-12 |
Editas Medicine, Inc. |
Systems for improving crispr/cas-mediated genome-editing
|
|
BR112017017812A2
(en)
|
2015-02-23 |
2018-04-10 |
Crispr Therapeutics Ag |
Materials and methods for treatment of hemoglobinopathies
|
|
WO2016135559A2
(en)
|
2015-02-23 |
2016-09-01 |
Crispr Therapeutics Ag |
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
US11021699B2
(en)
|
2015-04-29 |
2021-06-01 |
FioDesign Sonics, Inc. |
Separation using angled acoustic waves
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
GB201508026D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
US11474085B2
(en)
|
2015-07-28 |
2022-10-18 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
US11459540B2
(en)
|
2015-07-28 |
2022-10-04 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
EP3353296B1
(en)
|
2015-09-24 |
2020-11-04 |
Editas Medicine, Inc. |
Use of exonucleases to improve crispr/cas-mediated genome editing
|
|
US12043843B2
(en)
|
2015-11-04 |
2024-07-23 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of hemoglobinopathies
|
|
US11597924B2
(en)
|
2016-03-25 |
2023-03-07 |
Editas Medicine, Inc. |
Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
|
|
US11236313B2
(en)
|
2016-04-13 |
2022-02-01 |
Editas Medicine, Inc. |
Cas9 fusion molecules, gene editing systems, and methods of use thereof
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
US11085035B2
(en)
|
2016-05-03 |
2021-08-10 |
Flodesign Sonics, Inc. |
Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
|
|
CN110520530A
(zh)
|
2016-10-18 |
2019-11-29 |
明尼苏达大学董事会 |
肿瘤浸润性淋巴细胞和治疗方法
|
|
WO2018075830A1
(en)
|
2016-10-19 |
2018-04-26 |
Flodesign Sonics, Inc. |
Affinity cell extraction by acoustics
|
|
AU2017347854B2
(en)
*
|
2016-10-27 |
2022-12-08 |
Intima Bioscience, Inc. |
Viral methods of T cell therapy
|
|
CA3042179A1
(en)
|
2016-10-31 |
2018-05-03 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of expression of endogenous foxp3 gene
|
|
EP3612210A4
(en)
|
2017-04-19 |
2021-01-27 |
Board Of Regents, The University Of Texas System |
MANIPULATED ANTIGEN RECEPTORS EXPRESSING IMMUNE CELLS
|
|
EP3645021A4
(en)
*
|
2017-06-30 |
2021-04-21 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
|
US11866726B2
(en)
|
2017-07-14 |
2024-01-09 |
Editas Medicine, Inc. |
Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
|
|
BR112020008568A2
(pt)
|
2017-11-09 |
2020-10-06 |
Sangamo Therapeutics, Inc. |
modificação genética de gene de proteína contendo sh2 indutível por citoquina (cish)
|
|
AU2018378479B2
(en)
|
2017-12-05 |
2025-03-13 |
Vertex Pharmaceuticals Incorporated |
CRISPR-Cas9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof
|
|
KR102439221B1
(ko)
|
2017-12-14 |
2022-09-01 |
프로디자인 소닉스, 인크. |
음향 트랜스듀서 구동기 및 제어기
|
|
US11713446B2
(en)
*
|
2018-01-08 |
2023-08-01 |
Iovance Biotherapeutics, Inc. |
Processes for generating TIL products enriched for tumor antigen-specific T-cells
|
|
US11566236B2
(en)
|
2018-02-05 |
2023-01-31 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of hemoglobinopathies
|
|
US11268077B2
(en)
|
2018-02-05 |
2022-03-08 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of hemoglobinopathies
|
|
US12473336B2
(en)
|
2018-02-21 |
2025-11-18 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses thereof
|
|
US20190284553A1
(en)
|
2018-03-15 |
2019-09-19 |
KSQ Therapeutics, Inc. |
Gene-regulating compositions and methods for improved immunotherapy
|
|
CA3091491A1
(en)
*
|
2018-04-27 |
2019-10-31 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Expression of human foxp3 in gene edited t cells
|
|
WO2019210131A1
(en)
|
2018-04-27 |
2019-10-31 |
Iovance Biotherapeutics, Inc. |
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
AU2019261438B2
(en)
*
|
2018-04-27 |
2024-08-22 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Expression of FOXP3 in edited CD34+ cells
|
|
KR20210005240A
(ko)
*
|
2018-05-03 |
2021-01-13 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
면역 관문 차단과 함께 키메라 항원 수용체를 발현하도록 가공된 천연 킬러 세포
|
|
US20210322473A1
(en)
*
|
2018-07-18 |
2021-10-21 |
The General Hospital Corporation |
Modified t cells and methods of their use
|
|
US20210277120A1
(en)
*
|
2018-07-18 |
2021-09-09 |
The General Hospital Corporation |
Compositions and methods for treatment of t cell malignancies
|
|
CN110818802B
(zh)
*
|
2018-08-08 |
2022-02-08 |
华夏英泰（北京）生物技术有限公司 |
一种嵌合t细胞受体star及其应用
|
|
US20220056479A1
(en)
*
|
2018-12-17 |
2022-02-24 |
Cure Genetics Co., Ltd. |
Method For Delivering Gene In Cells
|
|
EP3921419B1
(en)
*
|
2019-02-08 |
2026-04-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Sirt2-ablated chimeric t cells
|
|
EP3927730A4
(en)
|
2019-02-20 |
2022-12-21 |
Rutgers, The State University of New Jersey |
EXPANSION OF NATURAL KILLER CELLS AND CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS
|
|
US20220154170A1
(en)
*
|
2019-03-01 |
2022-05-19 |
Fred Hutchinson Cancer Research Center |
Protein residue mapping using a combination of deep mutational scanning and phage display high throughput sequencing
|
|
EP3773918A4
(en)
|
2019-03-05 |
2022-01-05 |
Nkarta, Inc. |
CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY
|
|
SG11202110613SA
(en)
*
|
2019-03-27 |
2021-10-28 |
Res Inst Nationwide Childrens Hospital |
Generation of chimeric antigen receptor (car)-primary nk cells for cancer immunotherapy using a combination of cas9/rnp and aav viruses
|
|
US20220213469A1
(en)
*
|
2019-04-30 |
2022-07-07 |
The Broad Institute, Inc. |
Methods and compositions for barcoding nucleic acid libraries and cell populations
|
|
AU2020288829A1
(en)
*
|
2019-06-04 |
2021-12-02 |
Nkarta, Inc. |
Combinations of engineered natural killer cells and engineered T cells for immunotherapy
|
|
EP4017988A4
(en)
*
|
2019-08-19 |
2023-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
METHODS AND COMPOSITIONS FOR ENHANCEMENT AAV-MEDIATED HOMOLOGUE RECOMBINATION USING RIBONUCLEOTIDE REDUCTASE INHIBITORS
|
|
GB201913898D0
(en)
*
|
2019-09-26 |
2019-11-13 |
Lightbio Ltd |
Nucleic acid construct
|
|
IL291935A
(en)
*
|
2019-10-08 |
2022-06-01 |
Pact Pharma Inc |
Methods for immunotherapy of genetically modified autologous t cells
|
|
IL293946A
(en)
*
|
2019-12-18 |
2022-08-01 |
Editas Medicine Inc |
Engineered cells for therapy
|
|
KR20220147614A
(ko)
*
|
2020-02-28 |
2022-11-03 |
제넨테크, 인크. |
일차 골수 세포에서의 효율적인 유전체 편집
|
|
CN111420025B
(zh)
*
|
2020-04-28 |
2021-06-11 |
中国药科大学 |
茜草科类型环肽化合物在制备cGAS-STING信号通路激活剂的药物中的应用
|
|
CA3158133A1
(en)
|
2020-04-28 |
2021-11-04 |
Lyell Immunopharma, Inc. |
Methods for culturing cells
|
|
AU2021286655A1
(en)
|
2020-06-12 |
2023-01-05 |
Nkarta, Inc. |
Genetically modified natural killer cells for CD70-directed cancer immunotherapy
|
|
AU2021392094A1
(en)
*
|
2020-12-01 |
2023-07-06 |
Lepton Pharmaceuticals Ltd. |
Methods for enhancing therapeutic efficacy of isolated cells for cell therapy
|
|
WO2022125633A1
(en)
*
|
2020-12-08 |
2022-06-16 |
The Regents Of The University Of California |
Crispr ribonucleoprotein complex genome editing of human innate immune cells
|
|
CN113046357B
(zh)
*
|
2021-01-25 |
2023-05-16 |
柳州市柳铁中心医院 |
一种乐伐替尼耐药基因dusp9、其筛选方法及应用
|
|
CN112941105A
(zh)
*
|
2021-02-08 |
2021-06-11 |
江西农业大学 |
一种m6A“阅读器”YTHDF2基因改造方法及其应用
|
|
CN114058619B
(zh)
*
|
2021-11-19 |
2023-11-14 |
中国农业科学院兰州兽医研究所 |
Riplet敲除细胞系的构建及作为小核糖核酸病毒科病毒疫苗生产细胞系的应用
|
|
CN114621929B
(zh)
*
|
2021-12-21 |
2023-05-30 |
河南省肿瘤医院 |
一种抗肿瘤树突状细胞及其制备方法、表达载体及应用
|
|
WO2023178292A1
(en)
*
|
2022-03-16 |
2023-09-21 |
Regents Of The University Of Minnesota |
Genetically engineered t cell for cell therapy
|
|
AU2023353199A1
(en)
*
|
2022-09-27 |
2025-03-20 |
Genentech, Inc. |
Inhibition of genotoxic stress to improve t cell engineering
|
|
EP4661970A1
(en)
*
|
2023-02-07 |
2025-12-17 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Therapeutic base editing
|
|
WO2024220789A1
(en)
*
|
2023-04-21 |
2024-10-24 |
Regents Of The University Of Minnesota |
Cell lines and methods for producing recombinant adeno-associated virus
|
|
WO2025179160A1
(en)
*
|
2024-02-21 |
2025-08-28 |
Research Institute At Nationwide Children's Hospital |
Methods of increasing nk cell efficacy through inhibition of v-domain ig suppressor of t cell activation (vista)
|
|
CN121595402B
(zh)
*
|
2026-01-28 |
2026-04-17 |
信纳克(北京)生化标志物检测医学研究有限责任公司 |
用于鉴别异基因造血干细胞移植后腹泻致病成因的试剂盒与鉴别系统
|